The effects of laropiprant, a selective prostaglandin D2receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin-Reference-Cited by-同舟云学术

The effects of laropiprant, a selective prostaglandin D2receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin

Published:2011-10-12 Issue:7 Volume:22 Page:495-503
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

Dallob Aimee,Luo Wen-Lin,Luk Julie Mabalot,Ratcliffe Lisa,Johnson-Levonas Amy O.,Schwartz Jules I.,Dishy Victor,Kraft Walter K.,De Hoon Jan N.,Van Hecken Anne,De Lepeleire Inge,Radziszewski Waldemar,Wagner John A.,Lai Eseng

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/09537104.2011.565433

Reference27 articles.

1. Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease

2. Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review

3. The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target

4. Niacin dosing: Relationship to benefits and adverse effects

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Niacin Promotes Cardiac Healing after Myocardial Infarction through Activation of the Myeloid Prostaglandin D2 Receptor Subtype 1;Journal of Pharmacology and Experimental Therapeutics;2017-01-05

2. EDITORIAL: Repurposing Niacin as Antiplatelet Drug?;Current Clinical Pharmacology;2016-02-04

3. Niacin Alternatives for Dyslipidemia: Fool’s Gold or Gold Mine? Part I: Alternative Niacin Regimens;Current Atherosclerosis Reports;2016-02

4. Effect of Extended‐Release Niacin on High‐Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin‐Treated Patients;Journal of the American Heart Association;2015-09-16

5. Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients;New England Journal of Medicine;2014-07-17